English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
European Commission
Russell Boniface
| Sep 13, 2017
Merck's Keytruda wins European approval as bladder cancer treatment
Tabitha Fleming
| Jun 2, 2017
European Commission approves dinutuximab beta for treating high-risk neuroblastoma
Robert Hadley
| Apr 5, 2017
European Commission OKs Pfizer’s Xeljanz for rheumatoid arthritis treatment
Kyle Perrotti
| Mar 17, 2017
European Reference Networks help patients with complex diseases find diagnosis, treatment
Amanda Rupp
| Aug 9, 2016
Keytruda gains EC approval as advanced non-small cell lung cancer treatment
Amanda Rupp
| Jun 8, 2016
Positive CHMP opinion granted for Amgen relapsed multiple myeloma treatment
Amanda Rupp
| Jun 7, 2016
CHMP gives positive opinion of short bowl syndrome pediatric medicine
Amanda Rupp
| Jun 2, 2016
Imbruvica gains approval for treating chronic lymphocytic leukemia
Trending
+
Pharmaceuticals
Patient Daily
| Jun 30, 2025
PhRMA public affairs senior director on 340B program: 'PBMs took $140 billion in rebates and fees, driving up American medicine costs'
+
Pharmaceuticals
Patient Daily
| Jul 1, 2025
PhRMA chief public affairs officer on 340B drug pricing: ‘Lowering drug prices for U.S. patients starts by reining in middlemen’
+
Pharmaceuticals
Patient Daily
| Jul 1, 2025
American Lung Association launches campaign for World Bronchiectasis Day
+
Pharmaceuticals
Patient Daily
| Jul 1, 2025
Coalition warns against potential impact of H.R. 1 on patient healthcare access
